AI medical imaging analysis company AIDOT Inc. (CEO: Jaehun Jung) is participating in AdvanceMed 2026 in Ostrava, Czech Republic, showcasing its flagship solution Cerviray AI as part of its efforts to expand in the global medical AI market.
AdvanceMed 2026 is an international medical conference held from April 9 to 10, 2026, at Gong Hall in Dolní Vítkovice, Ostrava, Czech Republic. The event focuses on the application and commercialization of advanced technologies in healthcare, including AI, digital healthcare, and medical imaging.
Recognized as a global networking platform, the conference brings together medical professionals, researchers, and industry leaders from Europe and other regions.
At the event, AIDOT is introducing the core technology and clinical applications of Cerviray AI, while conducting on-site demonstrations for global healthcare professionals and potential partners.
Cerviray AI is an AI-powered cervical cancer diagnostic support solution that automatically detects suspected lesion areas based on cervical images and classifies lesions into four stages, from Normal to CIN3+. It also provides detailed lesion location detection, supporting more intuitive and informed clinical decision-making.
One of the key strengths of Cerviray AI is its on-device AI analysis. Medical data is processed directly on the device without being transmitted to external or overseas servers, offering strong advantages in data security and personal information protection.
Through its participation in AdvanceMed 2026, AIDOT plans to accelerate partnership expansion in the European market and strengthen its collaboration base with global medical institutions.
Key features of Cerviray AI include:
- On-device AI analysis with no internet connection required and immediate results
- MFDS Class III-approved AI medical device
- Four-stage lesion classification: Normal / CIN1 / CIN2-3 / CIN3+
- MFDS-approved lesion classification and detailed lesion detection box display
- Korea’s only AI cervical cancer diagnostic device designated as an Innovative Product by MOTIE
Korea Economic TV / 2026-04-10 / Yang Jaejun, Deputy Managing Editor
